OpenCapitalBeta

Calendar Stocks Metrics

/

Stocks
Eli Lilly
Business Segments
Products & Services
R&D

R&D

Eli Lilly·Products & Services·2 segments·Rolls up to R&D

Breakdown

Segments

Early-stageView metric

Late-stageView metric

Navigation

Earnings Calendar
Stocks
Pricing
About
Methodology

Connect

Claude (MCP)
ChatGPT (MCP)
Portfolio (Plaid)

Legal

Privacy Policy
Terms of Service
Cookie Policy
SEC EDGAR
support@opencapital.sh

© 2026 OpenCapital. All rights reserved.

Data sourced from SEC filings — methodology

OpenCapital is not affiliated with or endorsed by the U.S. Securities and Exchange Commission (SEC). All data is sourced from publicly available SEC filings.

OpenCapital

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Late-stage	$1.74B	$2.18B	$2.22B	$2.32B	$2.24B
Early-stage	$990.00M	$1.16B	$1.25B	$1.49B	$1.27B
Total	$2.73B	$3.34B	$3.47B	$3.80B	$3.51B